Biomarker Testing for Cancer Market, Global Outlook and Forecast 2024-2031

Report ID: 1647334 | Published Date: Sep 2024 | No. of Page: 73 | Base Year: 2023 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Biomarker Testing for Cancer Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Biomarker Testing for Cancer Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Biomarker Testing for Cancer Overall Market Size
    2.1 Global Biomarker Testing for Cancer Market Size: 2021 VS 2028
    2.2 Global Biomarker Testing for Cancer Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Biomarker Testing for Cancer Sales: 2017-2028
3 Company Landscape
    3.1 Top Biomarker Testing for Cancer Players in Global Market
    3.2 Top Global Biomarker Testing for Cancer Companies Ranked by Revenue
    3.3 Global Biomarker Testing for Cancer Revenue by Companies
    3.4 Global Biomarker Testing for Cancer Sales by Companies
    3.5 Global Biomarker Testing for Cancer Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Biomarker Testing for Cancer Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Biomarker Testing for Cancer Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Biomarker Testing for Cancer Players in Global Market
        3.8.1 List of Global Tier 1 Biomarker Testing for Cancer Companies
        3.8.2 List of Global Tier 2 and Tier 3 Biomarker Testing for Cancer Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Biomarker Testing for Cancer Market Size Markets, 2021 & 2028
        4.1.2 Protein Biomarkers
        4.1.3 Genetic Biomarkers
        4.1.4 Others
    4.2 By Type - Global Biomarker Testing for Cancer Revenue & Forecasts
        4.2.1 By Type - Global Biomarker Testing for Cancer Revenue, 2017-2022
        4.2.2 By Type - Global Biomarker Testing for Cancer Revenue, 2023-2028
        4.2.3 By Type - Global Biomarker Testing for Cancer Revenue Market Share, 2017-2028
    4.3 By Type - Global Biomarker Testing for Cancer Sales & Forecasts
        4.3.1 By Type - Global Biomarker Testing for Cancer Sales, 2017-2022
        4.3.2 By Type - Global Biomarker Testing for Cancer Sales, 2023-2028
        4.3.3 By Type - Global Biomarker Testing for Cancer Sales Market Share, 2017-2028
    4.4 By Type - Global Biomarker Testing for Cancer Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global Biomarker Testing for Cancer Market Size, 2021 & 2028
        5.1.2 Diagnostics
        5.1.3 Research & Development
        5.1.4 Prognostics
        5.1.5 Risk Assessment
        5.1.6 Others
    5.2 By Application - Global Biomarker Testing for Cancer Revenue & Forecasts
        5.2.1 By Application - Global Biomarker Testing for Cancer Revenue, 2017-2022
        5.2.2 By Application - Global Biomarker Testing for Cancer Revenue, 2023-2028
        5.2.3 By Application - Global Biomarker Testing for Cancer Revenue Market Share, 2017-2028
    5.3 By Application - Global Biomarker Testing for Cancer Sales & Forecasts
        5.3.1 By Application - Global Biomarker Testing for Cancer Sales, 2017-2022
        5.3.2 By Application - Global Biomarker Testing for Cancer Sales, 2023-2028
        5.3.3 By Application - Global Biomarker Testing for Cancer Sales Market Share, 2017-2028
    5.4 By Application - Global Biomarker Testing for Cancer Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Biomarker Testing for Cancer Market Size, 2021 & 2028
    6.2 By Region - Global Biomarker Testing for Cancer Revenue & Forecasts
        6.2.1 By Region - Global Biomarker Testing for Cancer Revenue, 2017-2022
        6.2.2 By Region - Global Biomarker Testing for Cancer Revenue, 2023-2028
        6.2.3 By Region - Global Biomarker Testing for Cancer Revenue Market Share, 2017-2028
    6.3 By Region - Global Biomarker Testing for Cancer Sales & Forecasts
        6.3.1 By Region - Global Biomarker Testing for Cancer Sales, 2017-2022
        6.3.2 By Region - Global Biomarker Testing for Cancer Sales, 2023-2028
        6.3.3 By Region - Global Biomarker Testing for Cancer Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Biomarker Testing for Cancer Revenue, 2017-2028
        6.4.2 By Country - North America Biomarker Testing for Cancer Sales, 2017-2028
        6.4.3 US Biomarker Testing for Cancer Market Size, 2017-2028
        6.4.4 Canada Biomarker Testing for Cancer Market Size, 2017-2028
        6.4.5 Mexico Biomarker Testing for Cancer Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Biomarker Testing for Cancer Revenue, 2017-2028
        6.5.2 By Country - Europe Biomarker Testing for Cancer Sales, 2017-2028
        6.5.3 Germany Biomarker Testing for Cancer Market Size, 2017-2028
        6.5.4 France Biomarker Testing for Cancer Market Size, 2017-2028
        6.5.5 U.K. Biomarker Testing for Cancer Market Size, 2017-2028
        6.5.6 Italy Biomarker Testing for Cancer Market Size, 2017-2028
        6.5.7 Russia Biomarker Testing for Cancer Market Size, 2017-2028
        6.5.8 Nordic Countries Biomarker Testing for Cancer Market Size, 2017-2028
        6.5.9 Benelux Biomarker Testing for Cancer Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Biomarker Testing for Cancer Revenue, 2017-2028
        6.6.2 By Region - Asia Biomarker Testing for Cancer Sales, 2017-2028
        6.6.3 China Biomarker Testing for Cancer Market Size, 2017-2028
        6.6.4 Japan Biomarker Testing for Cancer Market Size, 2017-2028
        6.6.5 South Korea Biomarker Testing for Cancer Market Size, 2017-2028
        6.6.6 Southeast Asia Biomarker Testing for Cancer Market Size, 2017-2028
        6.6.7 India Biomarker Testing for Cancer Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Biomarker Testing for Cancer Revenue, 2017-2028
        6.7.2 By Country - South America Biomarker Testing for Cancer Sales, 2017-2028
        6.7.3 Brazil Biomarker Testing for Cancer Market Size, 2017-2028
        6.7.4 Argentina Biomarker Testing for Cancer Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Biomarker Testing for Cancer Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Biomarker Testing for Cancer Sales, 2017-2028
        6.8.3 Turkey Biomarker Testing for Cancer Market Size, 2017-2028
        6.8.4 Israel Biomarker Testing for Cancer Market Size, 2017-2028
        6.8.5 Saudi Arabia Biomarker Testing for Cancer Market Size, 2017-2028
        6.8.6 UAE Biomarker Testing for Cancer Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 F. Hoffmann-L A Roche
        7.1.1 F. Hoffmann-L A Roche Corporate Summary
        7.1.2 F. Hoffmann-L A Roche Business Overview
        7.1.3 F. Hoffmann-L A Roche Biomarker Testing for Cancer Major Product Offerings
        7.1.4 F. Hoffmann-L A Roche Biomarker Testing for Cancer Sales and Revenue in Global (2017-2022)
        7.1.5 F. Hoffmann-L A Roche Key News
    7.2 Thermo Fisher Scientific
        7.2.1 Thermo Fisher Scientific Corporate Summary
        7.2.2 Thermo Fisher Scientific Business Overview
        7.2.3 Thermo Fisher Scientific Biomarker Testing for Cancer Major Product Offerings
        7.2.4 Thermo Fisher Scientific Biomarker Testing for Cancer Sales and Revenue in Global (2017-2022)
        7.2.5 Thermo Fisher Scientific Key News
    7.3 Qiagen N.V.
        7.3.1 Qiagen N.V. Corporate Summary
        7.3.2 Qiagen N.V. Business Overview
        7.3.3 Qiagen N.V. Biomarker Testing for Cancer Major Product Offerings
        7.3.4 Qiagen N.V. Biomarker Testing for Cancer Sales and Revenue in Global (2017-2022)
        7.3.5 Qiagen N.V. Key News
    7.4 Bio-Rad L aboratories
        7.4.1 Bio-Rad L aboratories Corporate Summary
        7.4.2 Bio-Rad L aboratories Business Overview
        7.4.3 Bio-Rad L aboratories Biomarker Testing for Cancer Major Product Offerings
        7.4.4 Bio-Rad L aboratories Biomarker Testing for Cancer Sales and Revenue in Global (2017-2022)
        7.4.5 Bio-Rad L aboratories Key News
    7.5 llumina
        7.5.1 llumina Corporate Summary
        7.5.2 llumina Business Overview
        7.5.3 llumina Biomarker Testing for Cancer Major Product Offerings
        7.5.4 llumina Biomarker Testing for Cancer Sales and Revenue in Global (2017-2022)
        7.5.5 llumina Key News
8 Global Biomarker Testing for Cancer Production Capacity, Analysis
    8.1 Global Biomarker Testing for Cancer Production Capacity, 2017-2028
    8.2 Biomarker Testing for Cancer Production Capacity of Key Manufacturers in Global Market
    8.3 Global Biomarker Testing for Cancer Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Biomarker Testing for Cancer Supply Chain Analysis
    10.1 Biomarker Testing for Cancer Industry Value Chain
    10.2 Biomarker Testing for Cancer Upstream Market
    10.3 Biomarker Testing for Cancer Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Biomarker Testing for Cancer Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

List of Tables
    Table 1. Key Players of Biomarker Testing for Cancer in Global Market
    Table 2. Top Biomarker Testing for Cancer Players in Global Market, Ranking by Revenue (2021)
    Table 3. Global Biomarker Testing for Cancer Revenue by Companies, (US$, Mn), 2017-2022
    Table 4. Global Biomarker Testing for Cancer Revenue Share by Companies, 2017-2022
    Table 5. Global Biomarker Testing for Cancer Sales by Companies, (K Units), 2017-2022
    Table 6. Global Biomarker Testing for Cancer Sales Share by Companies, 2017-2022
    Table 7. Key Manufacturers Biomarker Testing for Cancer Price (2017-2022) & (US$/Unit)
    Table 8. Global Manufacturers Biomarker Testing for Cancer Product Type
    Table 9. List of Global Tier 1 Biomarker Testing for Cancer Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Biomarker Testing for Cancer Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Biomarker Testing for Cancer Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Global Biomarker Testing for Cancer Revenue (US$, Mn), 2017-2022
    Table 13. By Type - Global Biomarker Testing for Cancer Revenue (US$, Mn), 2023-2028
    Table 14. By Type - Global Biomarker Testing for Cancer Sales (K Units), 2017-2022
    Table 15. By Type - Global Biomarker Testing for Cancer Sales (K Units), 2023-2028
    Table 16. By Application – Global Biomarker Testing for Cancer Revenue, (US$, Mn), 2021 & 2028
    Table 17. By Application - Global Biomarker Testing for Cancer Revenue (US$, Mn), 2017-2022
    Table 18. By Application - Global Biomarker Testing for Cancer Revenue (US$, Mn), 2023-2028
    Table 19. By Application - Global Biomarker Testing for Cancer Sales (K Units), 2017-2022
    Table 20. By Application - Global Biomarker Testing for Cancer Sales (K Units), 2023-2028
    Table 21. By Region – Global Biomarker Testing for Cancer Revenue, (US$, Mn), 2021 VS 2028
    Table 22. By Region - Global Biomarker Testing for Cancer Revenue (US$, Mn), 2017-2022
    Table 23. By Region - Global Biomarker Testing for Cancer Revenue (US$, Mn), 2023-2028
    Table 24. By Region - Global Biomarker Testing for Cancer Sales (K Units), 2017-2022
    Table 25. By Region - Global Biomarker Testing for Cancer Sales (K Units), 2023-2028
    Table 26. By Country - North America Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - North America Biomarker Testing for Cancer Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - North America Biomarker Testing for Cancer Sales, (K Units), 2017-2022
    Table 29. By Country - North America Biomarker Testing for Cancer Sales, (K Units), 2023-2028
    Table 30. By Country - Europe Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2022
    Table 31. By Country - Europe Biomarker Testing for Cancer Revenue, (US$, Mn), 2023-2028
    Table 32. By Country - Europe Biomarker Testing for Cancer Sales, (K Units), 2017-2022
    Table 33. By Country - Europe Biomarker Testing for Cancer Sales, (K Units), 2023-2028
    Table 34. By Region - Asia Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2022
    Table 35. By Region - Asia Biomarker Testing for Cancer Revenue, (US$, Mn), 2023-2028
    Table 36. By Region - Asia Biomarker Testing for Cancer Sales, (K Units), 2017-2022
    Table 37. By Region - Asia Biomarker Testing for Cancer Sales, (K Units), 2023-2028
    Table 38. By Country - South America Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2022
    Table 39. By Country - South America Biomarker Testing for Cancer Revenue, (US$, Mn), 2023-2028
    Table 40. By Country - South America Biomarker Testing for Cancer Sales, (K Units), 2017-2022
    Table 41. By Country - South America Biomarker Testing for Cancer Sales, (K Units), 2023-2028
    Table 42. By Country - Middle East & Africa Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2022
    Table 43. By Country - Middle East & Africa Biomarker Testing for Cancer Revenue, (US$, Mn), 2023-2028
    Table 44. By Country - Middle East & Africa Biomarker Testing for Cancer Sales, (K Units), 2017-2022
    Table 45. By Country - Middle East & Africa Biomarker Testing for Cancer Sales, (K Units), 2023-2028
    Table 46. F. Hoffmann-L A Roche Corporate Summary
    Table 47. F. Hoffmann-L A Roche Biomarker Testing for Cancer Product Offerings
    Table 48. F. Hoffmann-L A Roche Biomarker Testing for Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 49. Thermo Fisher Scientific Corporate Summary
    Table 50. Thermo Fisher Scientific Biomarker Testing for Cancer Product Offerings
    Table 51. Thermo Fisher Scientific Biomarker Testing for Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 52. Qiagen N.V. Corporate Summary
    Table 53. Qiagen N.V. Biomarker Testing for Cancer Product Offerings
    Table 54. Qiagen N.V. Biomarker Testing for Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 55. Bio-Rad L aboratories Corporate Summary
    Table 56. Bio-Rad L aboratories Biomarker Testing for Cancer Product Offerings
    Table 57. Bio-Rad L aboratories Biomarker Testing for Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 58. llumina Corporate Summary
    Table 59. llumina Biomarker Testing for Cancer Product Offerings
    Table 60. llumina Biomarker Testing for Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 61. Biomarker Testing for Cancer Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
    Table 62. Global Biomarker Testing for Cancer Capacity Market Share of Key Manufacturers, 2020-2022
    Table 63. Global Biomarker Testing for Cancer Production by Region, 2017-2022 (K Units)
    Table 64. Global Biomarker Testing for Cancer Production by Region, 2023-2028 (K Units)
    Table 65. Biomarker Testing for Cancer Market Opportunities & Trends in Global Market
    Table 66. Biomarker Testing for Cancer Market Drivers in Global Market
    Table 67. Biomarker Testing for Cancer Market Restraints in Global Market
    Table 68. Biomarker Testing for Cancer Raw Materials
    Table 69. Biomarker Testing for Cancer Raw Materials Suppliers in Global Market
    Table 70. Typical Biomarker Testing for Cancer Downstream
    Table 71. Biomarker Testing for Cancer Downstream Clients in Global Market
    Table 72. Biomarker Testing for Cancer Distributors and Sales Agents in Global Market
List of Figures
    Figure 1. Biomarker Testing for Cancer Segment by Type
    Figure 2. Biomarker Testing for Cancer Segment by Application
    Figure 3. Global Biomarker Testing for Cancer Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Biomarker Testing for Cancer Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Biomarker Testing for Cancer Revenue, 2017-2028 (US$, Mn)
    Figure 7. Biomarker Testing for Cancer Sales in Global Market: 2017-2028 (K Units)
    Figure 8. The Top 3 and 5 Players Market Share by Biomarker Testing for Cancer Revenue in 2021
    Figure 9. By Type - Global Biomarker Testing for Cancer Sales Market Share, 2017-2028
    Figure 10. By Type - Global Biomarker Testing for Cancer Revenue Market Share, 2017-2028
    Figure 11. By Type - Global Biomarker Testing for Cancer Price (US$/Unit), 2017-2028
    Figure 12. By Application - Global Biomarker Testing for Cancer Sales Market Share, 2017-2028
    Figure 13. By Application - Global Biomarker Testing for Cancer Revenue Market Share, 2017-2028
    Figure 14. By Application - Global Biomarker Testing for Cancer Price (US$/Unit), 2017-2028
    Figure 15. By Region - Global Biomarker Testing for Cancer Sales Market Share, 2017-2028
    Figure 16. By Region - Global Biomarker Testing for Cancer Revenue Market Share, 2017-2028
    Figure 17. By Country - North America Biomarker Testing for Cancer Revenue Market Share, 2017-2028
    Figure 18. By Country - North America Biomarker Testing for Cancer Sales Market Share, 2017-2028
    Figure 19. US Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
    Figure 20. Canada Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
    Figure 21. Mexico Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
    Figure 22. By Country - Europe Biomarker Testing for Cancer Revenue Market Share, 2017-2028
    Figure 23. By Country - Europe Biomarker Testing for Cancer Sales Market Share, 2017-2028
    Figure 24. Germany Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
    Figure 25. France Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
    Figure 26. U.K. Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
    Figure 27. Italy Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
    Figure 28. Russia Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
    Figure 29. Nordic Countries Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
    Figure 30. Benelux Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
    Figure 31. By Region - Asia Biomarker Testing for Cancer Revenue Market Share, 2017-2028
    Figure 32. By Region - Asia Biomarker Testing for Cancer Sales Market Share, 2017-2028
    Figure 33. China Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
    Figure 34. Japan Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
    Figure 35. South Korea Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
    Figure 36. Southeast Asia Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
    Figure 37. India Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
    Figure 38. By Country - South America Biomarker Testing for Cancer Revenue Market Share, 2017-2028
    Figure 39. By Country - South America Biomarker Testing for Cancer Sales Market Share, 2017-2028
    Figure 40. Brazil Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
    Figure 41. Argentina Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
    Figure 42. By Country - Middle East & Africa Biomarker Testing for Cancer Revenue Market Share, 2017-2028
    Figure 43. By Country - Middle East & Africa Biomarker Testing for Cancer Sales Market Share, 2017-2028
    Figure 44. Turkey Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
    Figure 45. Israel Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
    Figure 46. Saudi Arabia Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
    Figure 47. UAE Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
    Figure 48. Global Biomarker Testing for Cancer Production Capacity (K Units), 2017-2028
    Figure 49. The Percentage of Production Biomarker Testing for Cancer by Region, 2021 VS 2028
    Figure 50. Biomarker Testing for Cancer Industry Value Chain
    Figure 51. Marketing Channels
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
73
Frequently Asked Questions
Biomarker Testing for Cancer Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biomarker Testing for Cancer Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biomarker Testing for Cancer Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports